Join
Live feed
·
INSIDERFilingvia Quantisnow
Atea Pharmaceuticals Inc. logo

Director Duncan Barbara Gayle converted options into 33,150 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
AVIR· Atea Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AVIR (Atea Pharmaceuticals Inc.) and more on Quantisnow.